Lang James Paul
SEC CIK 1703090 · EDGAR
BoughtSold
Most active insiders at OPRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Silvestro Stephen L | CEO | — | $30.4K |
| 2 | Stelmakh Edward | Chief Fin, Strat Off | — | $18.8K |
| 3 | Presti Mariyamma Varghese | Dir | — | — |
| 4 | Merrell Brendan W. | COO | — | — |
| 5 | D'Silva Andrew J. | Chief Business Off | — | — |
| 6 | Greco Theresa | Chief Commercial Off | — | — |
| 7 | Besch Doug | Chief Product, Tech Off | — | — |
| 8 | Odence-Ford Marion | Chief Legal, Admin Off | — | — |
| 9 | Lang James Paul | Dir | — | — |
| 10 | Vos Ellen O'Connor | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-10 13:39 | 2026-06-09 | OPRX | OptimizeRx Corp | Lang James Paul | Dir | A - Grant | $0.00 | +34.5K | 433.8K | +9% | $0 | |
| D | 2026-05-07 19:03 | 2026-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Lang James Paul | Dir | A - Grant | $0.00 | +3,796 | 4,685 | +427% | $0 |
| D | 2026-01-06 | 2026-01-02 | HALO | HALOZYME THERAPEUTICS, INC. | Lang James Paul | Dir | A - Grant | $0.00 | +889 | 889 | New | $0 |
| 2025-06-12 | 2025-06-11 | OPRX | OptimizeRx Corp | Lang James Paul | Dir | A - Grant | $0.00 | +9,868 | 399.3K | +3% | $0 | |
| 2025-03-19 | 2025-03-14 | OPRX | OptimizeRx Corp | Lang James Paul | Dir | P - Purchase | $7.60 | +321.4K | 389.5K | +472% | +$2.44M | |
| D | 2024-06-11 | 2024-06-05 | OPRX | OptimizeRx Corp | Lang James Paul | Dir | M - OptEx | $0.00 | +10.1K | 54.8K | +23% | $0 |
| D | 2024-06-11 | 2024-06-07 | OPRX | OptimizeRx Corp | Lang James Paul | Dir | A - Grant | $0.00 | +13.3K | 68.0K | +24% | $0 |
| D | 2023-08-18 | 2023-06-07 | OPRX | OptimizeRx Corp | Lang James Paul | Dir | M - OptEx | $0.00 | +4,637 | 44.7K | +12% | $0 |
| D | 2023-04-03 | 2023-03-30 | OPRX | OptimizeRx Corp | Lang James Paul | Dir | M - OptEx | $0.00 | +657 | 40.1K | +2% | $0 |
| 2023-01-18 | 2022-11-23 | BIVI | BIOVIE INC. | Lang James Paul | Dir | A - Grant | $0.00 | +43.6K | 68.6K | +174% | $0 | |
| D | 2023-01-04 | 2022-12-30 | OPRX | OptimizeRx Corp | Lang James Paul | Dir | M - OptEx | $0.00 | +409 | 39.4K | +1% | $0 |
| D | 2022-09-30 | 2022-09-29 | OPRX | OptimizeRx Corp | Lang James Paul | Dir | M - OptEx | $0.00 | +334 | 39.0K | +0.9% | $0 |
| 2022-08-23 | 2022-08-19 | OPRX | OptimizeRx Corp | Lang James Paul | Dir | P - Purchase | $16.45 | +6,000 | 38.7K | +18% | +$98.7K |
Purchase Sale Sale after option exercise All abbreviations